v3.26.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Apr. 04, 2026
Mar. 29, 2025
Operating activities    
Net loss $ (287) $ (955)
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 4,210 4,035
Share-based compensation expense 837 545
Inventory write-offs for obsolescence 606 800
Deferred income tax expense (487) (489)
Foreign currency impacts and other items (73) 478
Accounts receivable (5,508) 1,823
Inventories (1,061) 227
Prepaid expenses and other current assets 958 (848)
Trade accounts payable 1,333 253
Other current liabilities (599) 292
Other non current assets and liabilities, net (463) (841)
Accrued pension and other postretirement costs, net (62) (71)
Net cash (used in) provided by operating activities (596) 5,249
Investing activities    
Capital expenditures (3,060) (1,507)
Net cash used in investing activities (3,060) (1,507)
Financing activities    
(Distributions) Contributions from noncontrolling interests (127) 147
Payments of employee taxes on certain share-based arrangements (375) (256)
Net cash used in financing activities (502) (109)
Effect of exchange rate changes on cash and cash equivalents (722) 987
(Decrease) Increase in cash and cash equivalents (4,880) 4,620
Cash and cash equivalents at beginning of period 87,366 79,272
Cash and cash equivalents at end of period 82,486 83,892
Supplemental disclosure of investing transactions:    
Capital expenditures accrued but not yet paid $ 796 $ 454